Case 29-2014: A 60-year-old woman with syncope

New England Journal of Medicine

Volumn 371, Issue 12, 2014, Pages 1143-1150

  Kabrhel, Christopher ^a,c   Rempell, Joshua S ^b   Avery, Laura L ^a,c   Dudzinski, David M ^a,c   Weinberg, Ido ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; HEPARIN; ANTICOAGULANT AGENT;

ABDOMINAL PAIN; ADULT; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; CARBON DIOXIDE BLOOD LEVEL; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DEEP VEIN THROMBOSIS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DYSPNEA; ECHOCARDIOGRAPHY; EMERGENCY CARE; EMERGENCY WARD; FAINTNESS; FEMALE; GASTROCNEMIUS MUSCLE; HEART RIGHT BUNDLE BRANCH BLOCK; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HYPOXEMIA; LUNG EMBOLISM; MUSCLE CRAMP; NAUSEA; OXYGEN NASAL CANNULA; OXYGEN SATURATION; ST SEGMENT DEPRESSION; SURGICAL THROMBECTOMY; T WAVE INVERSION; THORAX PAIN; THROMBOCYTOPENIA; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT PLANNING; UNCONSCIOUSNESS; VENOUS THROMBOEMBOLISM; VOMITING; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; ECHOGRAPHY; MIDDLE AGED; RADIOGRAPHY; THROMBECTOMY; VEIN THROMBOSIS;

ANTICOAGULANTS; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; FEMALE; HEPARIN; HUMANS; MIDDLE AGED; PULMONARY EMBOLISM; SYNCOPE; THROMBECTOMY; VENOUS THROMBOSIS;

EID: 84907410545     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc1403307     Document Type: Article

References (22)

1. Moore CL, Copel JA. Point-of-care ultrasonography. N Engl J Med 2011;364: 749-57.
2. Hockberger RS, Binder LS, Graber MA, et al. The model of the clinical practice of emergency medicine. Ann Emerg Med 2001;37:745-70.
3. Labovitz AJ, Noble VE, Bierig M, et al. Focused cardiac ultrasound in the emergent setting: a consensus statement of the American Society of Echocardiography and American College of Emergency Physicians. J Am Soc Echocardiogr 2010;23: 1225-30.
4. Dresden S, Mitchell P, Rahimi L, et al. Right ventricular dilatation on bedside echocardiography performed by emergency physicians aids in the diagnosis of pulmonary embolism. Ann Emerg Med 2014;63:16-24.
5. Rose PS, Punjabi NM, Pearse DB. Treatment of right heart thromboemboli. Chest 2002;121:806-14.
6. Torbicki A, Galié N, Covezzoli A, Rossi E, De Rosa M, Goldhaber SZ. Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol 2003;41:2245-51.
7. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011;123:1788-830. [Errata, Circulation 2012;125(11):e495, 126(7):e104.]
8. Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 2004;110:744-9.
9. Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hofmann LV. Catheterdirected therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol 2009;20:1431-40.
10. Leacche M, Unic D, Goldhaber SZ, et al. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg 2005;129:1018-23.
11. Takahashi H, Okada K, Matsumori M, Kano H, Kitagawa A, Okita Y. Aggressive surgical treatment of acute pulmonary embolism with circulatory collapse. Ann Thorac Surg 2012;94:785-91.
12. Boutitie F, Pinede L, Schulman S, et al. Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. BMJ 2011;342:d3036.
13. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141: Suppl:e419S-e494S. [Erratum, Chest 2012; 142:1698-704.]
14. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117:93-102.
15. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003;107:Suppl 1:I-9-I-16.
16. Watson HG. Travel and thrombosis. Blood Rev 2005;19:235-41.
17. Lee AY, Rickles FR, Julian JA, et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol 2005;23:2123-9.
18. Chong LY, Fenu E, Stansby G, Hodgkinson S. Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance. BMJ 2012;344:e3979.
19. Piccioli A, Lensing AW, Prins MH, et al. Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost 2004;2: 884-9.
20. Van Doormaal FF, Terpstra W, Van Der Griend R, et al. Is extensive screening for cancer in idiopathic venous thromboembolism warranted? J Thromb Haemost 2011;9:79-84.
21. Eichinger S, Heinze G, Kyrle PA. Ddimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model. J Am Heart Assoc 2014;3(1):e000467.
22. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998;279:458-62.